CONTINEUM THERAPEUTICS INC-A (CTNM) Stock News
NASDAQ:CTNM - US21217B1008 - Common Stock
10.4 USD
+0.35 (+3.48%)
CTNM Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: Contineum Therapeutics, Inc.
21 days ago - By: Zacks Investment Research
24 days ago - By: The Motley Fool
24 days ago - By: Contineum Therapeutics, Inc.
a year ago - By: BusinessInsider
2 months ago - By: Contineum Therapeutics, Inc.
4 months ago - By: Contineum Therapeutics, Inc.
4 months ago - By: Contineum Therapeutics, Inc.
4 months ago - By: Contineum Therapeutics, Inc.
5 months ago - By: Contineum Therapeutics, Inc.
6 months ago - By: Contineum Therapeutics, Inc.
6 months ago - By: Contineum Therapeutics, Inc.
6 months ago - By: Contineum Therapeutics, Inc.
6 months ago - By: Contineum Therapeutics, Inc.
8 months ago - By: Contineum Therapeutics, Inc.
8 months ago - By: RAPT Therapeutics, Inc. - Mentions: RAPT
9 months ago - By: Contineum Therapeutics, Inc.
9 months ago - By: Contineum Therapeutics, Inc.
9 months ago - By: Contineum Therapeutics, Inc.
10 months ago - By: Contineum Therapeutics, Inc.
10 months ago - By: Contineum Therapeutics, Inc.
a year ago - By: Contineum Therapeutics, Inc.
a year ago - By: InvestorPlace
a year ago - By: Contineum Therapeutics, Inc.
a year ago - By: Contineum Therapeutics, Inc.
a year ago - By: Contineum Therapeutics, Inc.
a year ago - By: Contineum Therapeutics, Inc.
a year ago - By: Contineum Therapeutics, Inc.
a year ago - By: Contineum Therapeutics, Inc.
